Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a support group for transgender adults who use substances

Tests a new mutual-help group for transgender adults with substance use or recent recovery.

Plain-language title generated from the registry record
Registry title: The Trans-Led Care Study

Key facts

Where
Chicago, United StatesSee the site

Where in United States

  • Illinois Institute of TechnologyChicago, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Illinois Institute of Technology
Trial code
NCT06880705
Record updated
5 November 2026
Original description
This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Therapy or "ACT" which is a type of mental health counseling that focuses on using mindfulness skills to connect a person to their values and improve their mental health. The TLC Program was developed by transgender and gender diverse community members, mental health providers, and researchers.Read full original descriptionShow less

A Gender-Affirming Stigma Intervention to Improve Substance Misuse and HIV Risk Among Transgender Women

This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Therapy or "ACT" which is a type of mental health counseling that focuses on using mindfulness skills to connect a person to their values and improve their mental health. The TLC Program was developed by transgender and gender diverse community members, mental health providers, and researchers.

Inclusion: Eligible transgender adults must:; be 18 years of age or older; speak primarily English; live in the U.S; have a gender identity different from their assumed gender, or sex assigned, at birth; identify as a person of transgender experience; endorse having experienced two or more problem(s) related to alcohol or other drug use within the past 12 months.

ClinicalTrials.gov NCT06880705